AI Infrastructure and Asset Divestitures Drive Q2 Divergence Across Disparate Sectors

Capital deployment in the back half of 2026 is brutally efficient, rewarding companies that can either monetize AI infrastructure or ruthlessly trim excess operational fat. We are seeing a distinct rotation where tech-forward pivots are driving outsized gains across fundamentally different sectors, from digital assets to heavy industry.

At the raw compute layer, HIVE Digital Technologies (HIVE.US) is aggressively transitioning its operational weight toward high-performance computing. A strategic five-year pact with Bell Canada sets the stage for a $300 million AI Gigafactory, pushing HIVE toward a massive $1 billion long-term revenue target. In the automotive silicon space, Indie Semiconductor (INDI.US) delivered a 24% top-line beat in Q2, fueled by global OEM adoptions of its next-gen edge AI vision processors. Meanwhile, Unity Software (U.US) took the divestiture route, offloading its Supersonic publishing arm to double down on core software engine growth—a streamlined strategy that pushed Q2 revenue to $546.5 million and sent shares sharply higher.

Financial technology is facing its own structural reckoning as credit conditions evolve. Pagaya Technologies (PGY.US) printed a record $3.5 billion in network volume in Q2, translating into a solid $45 million GAAP net income despite a tightening macro backdrop. Fiserv (FISV.US) posted a massive $3.4 billion in quarterly revenue, yet activist investor Jana Partners is actively applying pressure for a strategic review and potential asset sales to unlock shareholder value. On the decentralized front, DeFi Technologies (DEFT.US) is navigating a tougher tape, reporting a $2.3 million operating loss in Q2 as it adjusts to ongoing crypto market volatility.

Capital intensive sectors are showing intense divergence based entirely on cash burn and strategic acquisitions. Summit Therapeutics (SMMT.US) saw its shares slide recently; despite scoring a major Chinese regulatory approval for its cancer drug ivonescimab, a staggering $405.1 million net loss in the first half of the year spooked investors worried about cash runway. In stark contrast, infrastructure plays are sizing up for stability, with Macquarie Infrastructure (MRAAY.US) leading a consortium to acquire Australian logistics powerhouse Qube for roughly AUD 11.7 billion to secure regional supply chain dominance.

The most striking margin expansion narrative is happening where legacy industry meets silicon. Vale S.A. (VALE.US) generated $3.68 billion in adjusted EBITDA last quarter, heavily supported by AI and automation deployments that drove a 25% productivity spike at its Brazilian iron ore sites. Similarly, Waste Management (WM.US) is leaning heavily into autonomous equipment testing for its "Landfill of the Future" initiative, a tech-forward operational shift that helped boost operating cash flow by nearly 12% and returned over $1 billion to shareholders in a single quarter.